Back to Agenda
Navigating the New FDA: Insights from Former FDA Chief of Staffs
Session Chair(s)
Elizabeth Lange, MPH, MS
Executive Director/ Head of Regulatory Scientific Policy
EMD Serono, United States
The session will feature former FDA Chief of Staffs discussing their contributions to regulatory policies, patient engagement, and innovative technologies, offering insights into the evolving regulatory landscape and helping stakeholders navigate FDA
Learning Objective : Discover key initiatives and challenges from former FDA Chief of Staffs; Understand the evolving regulatory landscape and future drug approval processes; Explore FDA dynamics and strategic decisions that influence public health, helping stakeholders navigate the new FDA.
Have an account?